Subsequent studies in mice or rats [34] have shown that CER inhibited spontaneous neoplasias in p53-deficient mice [35]; chemically-induced mammary [36], liver [37], or bladder [38] tumors; or radiation-induced tumors [39]. Here, TP53 is linked to neoplasm.